Reported Earnings • May 17
Full year 2026 earnings released: EPS: ₹9.59 (vs ₹13.06 in FY 2025) Full year 2026 results: EPS: ₹9.59 (down from ₹13.06 in FY 2025). Revenue: ₹2.53b (up 25% from FY 2025). Net income: ₹128.9m (down 27% from FY 2025). Profit margin: 5.1% (down from 8.7% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings. New Risk • May 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10% average weekly change). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.5% net profit margin). Market cap is less than US$100m (₹2.56b market cap, or US$27.2m). Valuation Update With 7 Day Price Move • May 05
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹179, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 67% over the past three years. Valuation Update With 7 Day Price Move • Apr 02
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹142, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 37% over the past three years. Recent Insider Transactions • Mar 08
Chairman & MD recently bought ₹1.9m worth of stock On the 2nd of March, Sameer Shah bought around 13k shares on-market at roughly ₹144 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Sameer's only on-market trade for the last 12 months. Duyuru • Jan 27
Chembond Material Technologies Limited announces Annual dividend, payable on August 19, 2025 Chembond Material Technologies Limited announced Annual dividend of INR 1.7500 per share payable on August 19, 2025, ex-date on July 31, 2025 and record date on July 31, 2025. Reported Earnings • Jan 17
Third quarter 2026 earnings released: EPS: ₹1.18 (vs ₹8.71 in 3Q 2025) Third quarter 2026 results: EPS: ₹1.18 (down from ₹8.71 in 3Q 2025). Revenue: ₹644.5m (down 49% from 3Q 2025). Net income: ₹15.9m (down 86% from 3Q 2025). Profit margin: 2.5% (down from 9.3% in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 16% per year and the company’s share price has also fallen by 16% per year. Reported Earnings • Oct 19
Second quarter 2026 earnings released: EPS: ₹2.85 (vs ₹10.31 in 2Q 2025) Second quarter 2026 results: EPS: ₹2.85 (down from ₹10.31 in 2Q 2025). Revenue: ₹578.8m (down 53% from 2Q 2025). Net income: ₹38.3m (down 72% from 2Q 2025). Profit margin: 6.6% (down from 11% in 2Q 2025). Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Board Change • Aug 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Additional Independent Director Kamal Tandon was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Declared Dividend • Jul 25
Final dividend of ₹1.75 announced Shareholders will receive a dividend of ₹1.75. Ex-date: 31st July 2025 Payment date: 19th August 2025 Dividend yield will be 171%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (13% earnings payout ratio) and cash flows (16% cash payout ratio). The dividend has increased by an average of 1.6% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 56% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Jul 24
Full year 2025 earnings released: EPS: ₹13.06 (vs ₹8.31 in FY 2024) Full year 2025 results: EPS: ₹13.06 (up from ₹8.31 in FY 2024). Revenue: ₹2.02b (up 13% from FY 2024). Net income: ₹175.6m (up 57% from FY 2024). Profit margin: 8.7% (up from 6.3% in FY 2024). Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Duyuru • Jul 17
Chembond Material Technologies Limited to Report Q1, 2026 Results on Jul 26, 2025 Chembond Material Technologies Limited announced that they will report Q1, 2026 results at 12:15 PM, Indian Standard Time on Jul 26, 2025 Declared Dividend • Jul 12
Dividend reduced to ₹1.75 Dividend of ₹1.75 is 50% lower than last year. Ex-date: 31st July 2025 Payment date: 13th September 2025 Dividend yield will be 0.8%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (13% earnings payout ratio) and cash flows (16% cash payout ratio). The dividend has increased by an average of 1.6% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 56% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Duyuru • Jul 10
Chembond Material Technologies Limited, Annual General Meeting, Aug 14, 2025 Chembond Material Technologies Limited, Annual General Meeting, Aug 14, 2025. Reported Earnings • May 31
Full year 2025 earnings released: EPS: ₹13.06 (vs ₹33.02 in FY 2024) Full year 2025 results: EPS: ₹13.06 (down from ₹33.02 in FY 2024). Revenue: ₹2.09b (down 55% from FY 2024). Net income: ₹175.6m (down 61% from FY 2024). Profit margin: 8.4% (down from 9.6% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Duyuru • May 19
Chembond Chemicals Limited to Report Q4, 2025 Results on May 30, 2025 Chembond Chemicals Limited announced that they will report Q4, 2025 results at 12:15 PM, Indian Standard Time on May 30, 2025 New Risk • May 09
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 5.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (5.4% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Market cap is less than US$100m (₹7.39b market cap, or US$86.1m). Valuation Update With 7 Day Price Move • May 09
Investor sentiment deteriorates as stock falls 34% After last week's 34% share price decline to ₹342, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 108% over the past three years. Board Change • Mar 26
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Additional Non-Executive Independent Director Jayesh Shah was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Duyuru • Mar 25
Chembond Chemicals Limited Announces Cessation of Saraswati Sankar as Independent Director Chembond Chemicals Limited inform that the second consecutive term of appointment of Mrs. Saraswati Sankar (DIN: 07133249) as an Independent Director of the Company has ended on March 23, 2025. Consequently, Mrs. Saraswati Sankar has ceased to be an Independent Director of the Company with effect from March 24, 2025. Reported Earnings • Jan 25
Third quarter 2025 earnings released: EPS: ₹8.71 (vs ₹10.04 in 3Q 2024) Third quarter 2025 results: EPS: ₹8.71 (down from ₹10.04 in 3Q 2024). Revenue: ₹1.27b (up 10% from 3Q 2024). Net income: ₹117.2m (down 13% from 3Q 2024). Profit margin: 9.3% (down from 12% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 45% per year whereas the company’s share price has increased by 46% per year. Duyuru • Jan 16
Chembond Chemicals Limited to Report Q3, 2025 Results on Jan 24, 2025 Chembond Chemicals Limited announced that they will report Q3, 2025 results on Jan 24, 2025 Reported Earnings • Oct 26
Second quarter 2025 earnings released: EPS: ₹10.31 (vs ₹11.48 in 2Q 2024) Second quarter 2025 results: EPS: ₹10.31 (down from ₹11.48 in 2Q 2024). Revenue: ₹1.29b (up 15% from 2Q 2024). Net income: ₹138.7m (down 10% from 2Q 2024). Profit margin: 11% (down from 14% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 38% per year, which means it is significantly lagging earnings growth. Duyuru • Oct 17
Chembond Chemicals Limited to Report Q2, 2025 Results on Oct 25, 2024 Chembond Chemicals Limited announced that they will report Q2, 2025 results on Oct 25, 2024 Recent Insider Transactions • Sep 04
Vice Chairman & MD recently bought ₹8.0m worth of stock On the 30th of August, Nirmal Shah bought around 13k shares on-market at roughly ₹628 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Nirmal's only on-market trade for the last 12 months. Duyuru • Aug 09
Chembond Chemicals Limited Announces the Cessation of Directors Chembond Chemicals Limited informed that Mr. Mahendra Ghelani (DIN: 01108297) and Mr. Sushil Lakhani (DIN: 01578957) ceased to be Independent Directors of the Company upon completion of their second term of 5 (Five) consecutive years at the close of business hours on August 8, 2024. New Risk • Jul 19
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₹8.21b (US$98.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.4% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₹8.21b market cap, or US$98.1m). Duyuru • Jul 18
Chembond Chemicals Limited to Report Q1, 2025 Results on Jul 26, 2024 Chembond Chemicals Limited announced that they will report Q1, 2025 results on Jul 26, 2024 Reported Earnings • Jul 16
Full year 2024 earnings released: EPS: ₹33.02 (vs ₹18.66 in FY 2023) Full year 2024 results: EPS: ₹33.02 (up from ₹18.66 in FY 2023). Revenue: ₹4.62b (up 4.9% from FY 2023). Net income: ₹444.1m (up 77% from FY 2023). Profit margin: 9.6% (up from 5.7% in FY 2023). Over the last 3 years on average, earnings per share has increased by 39% per year whereas the company’s share price has increased by 40% per year. Declared Dividend • Jul 05
Dividend increased to ₹3.50 Dividend of ₹3.50 is 17% higher than last year. Ex-date: 22nd July 2024 Payment date: 6th September 2024 Dividend yield will be 0.5%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (11% earnings payout ratio) and cash flows (30% cash payout ratio). The dividend has increased by an average of 9.4% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 21% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Duyuru • Jul 04
Chembond Chemicals Limited, Annual General Meeting, Aug 07, 2024 Chembond Chemicals Limited, Annual General Meeting, Aug 07, 2024. New Risk • Jun 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (₹6.87b market cap, or US$82.2m). Valuation Update With 7 Day Price Move • Jun 12
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to ₹614, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 213% over the past three years. Duyuru • May 26
Chembond Chemicals Limited Recommends Dividend for the Financial Year Ended 31 March 2024 Chembond Chemicals Limited announced that at the board meeting held on May 25, 2024, recommended Dividend of INR 3.50 (Rupees Three and Fifty Paise only) per equity share for the financial year ended March 31, 2024 subject to the approval of the members in the up coming Annual General Meeting (AGM). The dividend will be paid within 30 days from the date of approval by the members at the up coming AGM of the Company. Duyuru • May 18
Chembond Chemicals Limited to Report Q4, 2024 Results on May 25, 2024 Chembond Chemicals Limited announced that they will report Q4, 2024 results on May 25, 2024 Reported Earnings • Jan 26
Third quarter 2024 earnings released: EPS: ₹10.04 (vs ₹6.13 in 3Q 2023) Third quarter 2024 results: EPS: ₹10.04 (up from ₹6.13 in 3Q 2023). Revenue: ₹1.18b (up 6.8% from 3Q 2023). Net income: ₹135.0m (up 64% from 3Q 2023). Profit margin: 11% (up from 7.5% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth. Duyuru • Jan 18
Chembond Chemicals Limited to Report Q3, 2024 Results on Jan 25, 2024 Chembond Chemicals Limited announced that they will report Q3, 2024 results on Jan 25, 2024 Valuation Update With 7 Day Price Move • Jan 05
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹605, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 256% over the past three years. Recent Insider Transactions • Nov 15
Vice Chairman & MD recently bought ₹89k worth of stock On the 12th of November, Nirmal Shah bought around 200 shares on-market at roughly ₹446 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Nirmal's only on-market trade for the last 12 months. Valuation Update With 7 Day Price Move • Nov 11
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹443, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 195% over the past three years. New Risk • Nov 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 53x cash flows per share). Share price has been volatile over the past 3 months (7.7% average weekly change). Market cap is less than US$100m (₹5.98b market cap, or US$71.9m). Reported Earnings • Nov 06
Second quarter 2024 earnings released: EPS: ₹11.48 (vs ₹5.66 in 2Q 2023) Second quarter 2024 results: EPS: ₹11.48 (up from ₹5.66 in 2Q 2023). Revenue: ₹1.21b (up 10% from 2Q 2023). Net income: ₹154.4m (up 103% from 2Q 2023). Profit margin: 13% (up from 6.9% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year whereas the company’s share price has increased by 34% per year. Duyuru • Aug 05
Chembond Chemicals Limited to Report Q1, 2024 Results on Aug 12, 2023 Chembond Chemicals Limited announced that they will report Q1, 2024 results at 3:30 PM, Indian Standard Time on Aug 12, 2023 Reported Earnings • Jul 28
Full year 2023 earnings released: EPS: ₹18.36 (vs ₹10.35 in FY 2022) Full year 2023 results: EPS: ₹18.36 (up from ₹10.35 in FY 2022). Revenue: ₹4.40b (up 26% from FY 2022). Net income: ₹246.9m (up 77% from FY 2022). Profit margin: 5.6% (up from 4.0% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year whereas the company’s share price has increased by 39% per year. Upcoming Dividend • Jul 27
Upcoming dividend of ₹3.00 per share at 0.7% yield Eligible shareholders must have bought the stock before 03 August 2023. Payment date: 18 September 2023. Payout ratio is a comfortable 16% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%). Duyuru • Jul 07
Chembond Chemicals Limited Proposes Dividend for the Year Ended 31St March, 2023 Chembond Chemicals Limited announced that the Board of Directors at their Meeting held on 20th May, 2023 have declared a Dividend of INR 3 per Equity Share of INR 5 each for the financial year ended 31st March, 2023, subject to approval of shareholders at the 48th Annual General Meeting to be held on 19th August, 2023. Duyuru • Jul 04
Chembond Chemicals Limited, Annual General Meeting, Aug 19, 2023 Chembond Chemicals Limited, Annual General Meeting, Aug 19, 2023. Agenda: To consider the dividend. Valuation Update With 7 Day Price Move • May 27
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹366, the stock trades at a trailing P/E ratio of 19.9x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 178% over the past three years. Duyuru • May 21
Chembond Chemicals Limited Recommends Dividend for the Financial Year Ended 31 March 2023 Chembond Chemicals Limited announced that at its board meeting held on 20 May 2023, recommended dividend of INR 3.00 per equity share for the financial year ended 31 March 2023 subject to the approval of the members in the upcoming Annual General Meeting (AGM). The dividend will be paid within 30 days from the date of approval by the members at the upcoming AGM of the company. Reported Earnings • May 20
Full year 2023 earnings released: EPS: ₹18.36 (vs ₹10.35 in FY 2022) Full year 2023 results: EPS: ₹18.36 (up from ₹10.35 in FY 2022). Revenue: ₹4.45b (up 27% from FY 2022). Net income: ₹246.9m (up 77% from FY 2022). Profit margin: 5.5% (up from 4.0% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth. Duyuru • May 13
Chembond Chemicals Limited to Report Q4, 2023 Results on May 20, 2023 Chembond Chemicals Limited announced that they will report Q4, 2023 results at 3:30 PM, Indian Standard Time on May 20, 2023 Valuation Update With 7 Day Price Move • May 12
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹320, the stock trades at a trailing P/E ratio of 25.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 135% over the past three years. Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹281, the stock trades at a trailing P/E ratio of 22.7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 90% over the past three years. Reported Earnings • Jan 23
Third quarter 2023 earnings released: EPS: ₹6.13 (vs ₹1.76 in 3Q 2022) Third quarter 2023 results: EPS: ₹6.13 (up from ₹1.76 in 3Q 2022). Revenue: ₹1.12b (up 20% from 3Q 2022). Net income: ₹82.5m (up 249% from 3Q 2022). Profit margin: 7.4% (up from 2.5% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Duyuru • Jan 13
Chembond Chemicals Limited to Report Q4, 2023 Results on Jan 21, 2023 Chembond Chemicals Limited announced that they will report Q4, 2023 results on Jan 21, 2023 Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. Independent & Non-Executive Director Prakash Trivedi was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Oct 29
Chairman & MD recently bought ₹880k worth of stock On the 24th of October, Sameer Shah bought around 4k shares on-market at roughly ₹205 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth ₹7.3m. Sameer has been a buyer over the last 12 months, purchasing a net total of ₹12m worth in shares. Reported Earnings • Oct 21
Second quarter 2023 earnings released: EPS: ₹5.66 (vs ₹3.48 in 2Q 2022) Second quarter 2023 results: EPS: ₹5.66 (up from ₹3.48 in 2Q 2022). Revenue: ₹1.12b (up 34% from 2Q 2022). Net income: ₹76.1m (up 63% from 2Q 2022). Profit margin: 6.8% (up from 5.6% in 2Q 2022). Recent Insider Transactions • Aug 15
Chairman & MD recently bought ₹7.3m worth of stock On the 11th of August, Sameer Shah bought around 45k shares on-market at roughly ₹161 per share. This was the largest purchase by an insider in the last 3 months. Sameer has been a buyer over the last 12 months, purchasing a net total of ₹16m worth in shares. Reported Earnings • Jul 30
First quarter 2023 earnings released: ₹1.02 loss per share (vs ₹3.56 profit in 1Q 2022) First quarter 2023 results: ₹1.02 loss per share (down from ₹3.56 profit in 1Q 2022). Revenue: ₹980.5m (up 26% from 1Q 2022). Net loss: ₹13.7m (down 129% from profit in 1Q 2022). Board Change • Jul 21
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. Independent & Non-Executive Director Prakash Trivedi was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Mar 12
Vice Chairman & MD recently bought ₹312k worth of stock On the 7th of March, Nirmal Shah bought around 2k shares on-market at roughly ₹169 per share. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.9m. Nirmal has been a buyer over the last 12 months, purchasing a net total of ₹7.1m worth in shares. Recent Insider Transactions • Mar 05
Vice Chairman & MD recently bought ₹1.0m worth of stock On the 25th of February, Nirmal Shah bought around 6k shares on-market at roughly ₹172 per share. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.9m. Nirmal has been a buyer over the last 12 months, purchasing a net total of ₹6.8m worth in shares. Buying Opportunity • Feb 24
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 17%. The fair value is estimated to be ₹217, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 7.3% per annum over the last 3 years. Recent Insider Transactions • Feb 18
Chairman & MD recently bought ₹1.8m worth of stock On the 15th of February, Sameer Shah bought around 10k shares on-market at roughly ₹187 per share. In the last 3 months, they made an even bigger purchase worth ₹1.9m. Sameer has been a buyer over the last 12 months, purchasing a net total of ₹9.1m worth in shares. Recent Insider Transactions • Jan 30
Vice Chairman & MD recently bought ₹1.3m worth of stock On the 24th of January, Nirmal Shah bought around 7k shares on-market at roughly ₹192 per share. This was the largest purchase by an insider in the last 3 months. Nirmal has been a buyer over the last 12 months, purchasing a net total of ₹5.7m worth in shares. Reported Earnings • Jan 21
Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint Third quarter 2022 results: EPS: ₹1.76 (down from ₹6.28 in 3Q 2021). Revenue: ₹934.8m (up 24% from 3Q 2021). Net income: ₹23.6m (down 72% from 3Q 2021). Profit margin: 2.5% (down from 11% in 3Q 2021). Revenue missed analyst estimates by 7.7%. Reported Earnings • Nov 01
Second quarter 2022 earnings released The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹872.1m (up 30% from 2Q 2021). Net income: ₹46.9m (up 48% from 2Q 2021). Profit margin: 5.4% (up from 4.7% in 2Q 2021). Valuation Update With 7 Day Price Move • Oct 06
Investor sentiment improved over the past week After last week's 17% share price gain to ₹267, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 83% over the past year. Recent Insider Transactions • Sep 16
Chairman & MD recently bought ₹5.4m worth of stock On the 13th of September, Sameer Shah bought around 25k shares on-market at roughly ₹221 per share. This was the largest purchase by an insider in the last 3 months. Sameer has been a buyer over the last 12 months, purchasing a net total of ₹5.5m worth in shares. Valuation Update With 7 Day Price Move • Aug 11
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₹212, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 36% over the past year. Reported Earnings • Jul 02
Full year 2021 earnings released: EPS ₹15.13 (vs ₹1.39 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹2.74b (up 2.4% from FY 2020). Net income: ₹203.4m (up ₹184.7m from FY 2020). Profit margin: 7.4% (up from 0.7% in FY 2020). Upcoming Dividend • Jul 01
Upcoming dividend of ₹2.25 per share Eligible shareholders must have bought the stock before 07 July 2021. Payment date: 22 August 2021. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.7%). Reported Earnings • May 16
Full year 2021 earnings released The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹2.90b (up 8.1% from FY 2020). Net income: ₹203.4m (up ₹184.7m from FY 2020). Profit margin: 7.0% (up from 0.7% in FY 2020). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Apr 29
Investor sentiment improved over the past week After last week's 16% share price gain to ₹211, the stock trades at a trailing P/E ratio of 31.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 38% over the past year. Is New 90 Day High Low • Jan 18
New 90-day high: ₹209 The company is up 45% from its price of ₹145 on 20 October 2020. The Indian market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period. Reported Earnings • Jan 17
Third quarter 2021 earnings released: EPS ₹6.28 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹752.0m (up 9.8% from 3Q 2020). Net income: ₹84.5m (up 248% from 3Q 2020). Profit margin: 11% (up from 3.5% in 3Q 2020). The increase in margin was driven by higher revenue. Is New 90 Day High Low • Dec 03
New 90-day high: ₹171 The company is up 5.0% from its price of ₹163 on 04 September 2020. The Indian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Reported Earnings • Nov 08
Second quarter 2021 earnings released: EPS ₹2.35 The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹688.9m (up 5.5% from 2Q 2020). Net income: ₹31.6m (up 107% from 2Q 2020). Profit margin: 4.6% (up from 2.3% in 2Q 2020). The increase in margin was driven by higher revenue.